Skip to main content
Judith Shizuru, MD, Oncology, Stanford, CA

JudithA.ShizuruMD

Oncology Stanford, CA

Associate Professor, Medicine - Blood & Marrow Transplantation, Stanford University Medical Center

Are you Dr. Shizuru?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 48 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000

Summary

  • Dr. Judith Shizuru, MD is an oncologist in Stanford, California. She is currently licensed to practice medicine in California. She is affiliated with Stanford Health Care and is an Associate Professor at Stanford University Medical Center.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1994 - 1997
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1992 - 1994
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1992

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1994 - 2026
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Fred Hutch Hosts Inaugural Dr. E. Donnall Thomas Symposium
    Fred Hutch Hosts Inaugural Dr. E. Donnall Thomas SymposiumOctober 7th, 2022
  • Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood Cancers
    Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 2nd, 2021
  • Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting & Exposition
    Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting & ExpositionDecember 9th, 2019
  • Join now to see all

Grant Support

  • Overcoming Resistance To Engraftment In Non-Myeloablated RecipientsNational Heart, Lung, And Blood Institute2010–2011
  • Transplantation Of Purified Hematopoietic Cell Populations Acroos Allogenic BarieNational Cancer Institute2007–2011
  • Isolation And Transplantation Of Candidate Alveolar Progenitor CellsNational Heart, Lung, And Blood Institute2007–2010
  • Barriers To Allogeneic Hematopoietic Stem Cell EngraftmentNational Heart, Lung, And Blood Institute2007–2010
  • Isolation And Characterization Of Lung Alveolar ProgenitorsNational Heart, Lung, And Blood Institute2007
  • Diabetes Allele Transfer By Hematopoietic Cell Transpl.National Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
  • Hematopoietic Cell Transplants For Autoimmune DiseasesNational Institute Of Allergy And Infectious Diseases2001–2005
  • Barriers To Allogenic Transplantation Of Purified Hsc'SNational Cancer Institute2002